Breathe Well Live Well
|
Harvard Clinical Research Institute Initiates Comparative Effectiveness Study …
Genetic Engineering News Tiotropium) Study, the purpose of which is to investigate whether Black patients with asthma are more likely to experience adverse outcomes as a result of long-acting beta-agonist (LABA) therapy. The BELT study was funded by a grant from the Agency for … |
View full post on asthma – Google News
Clinical features and outcome of hospitalised adults and children with the 2009 influenza A H1N1 infection at Geneva’s University Hospital.
Swiss Med Wkly. 2011;141:w13177
Authors: Lücker LM, Kherad O, Iten A, Wagner N, Descombes M, Camus V, Kaiser L, Louis-Simonet M
To describe the clinical features and outcomes of hospitalised cases of the 2009 influenza A H1N1 virus infection at Geneva’s University Hospital during the peak of the epidemic.
PMID: 21416409 [PubMed – in process]
View full post on pubmed: asthma
 LiveScience.com |
Omalizumab improves asthma control in inner-city children
Clinical Advisor Adding omalizumab to guidelines-directed asthma therapy reduces seasonal exacerbations and the need for controller medication among inner-city children, regardless of asthma severity, results from the Inner City Anti-IgE Therapy for Asthma (ICATA) … Omalizumab 'cuts seasonal asthma attacks in youth' Drug may relieve kids' asthma in the fall Asthma Drug Cuts Seasonal Flares for Inner-City Kids |
View full post on asthma – Google News
|
FDA Clears Palatin Technologies' IND Filing to Commence Clinical Studies for …
AUTO-MOBI.info (press release) "We are excited about the prospect of advancing PL-3994 into a Phase 2A human trial to treat asthma patients," stated Dr. Carl Spana, Palatin's Chief Executive Officer. "Existing therapies for acute exacerbations of asthma in patients unresponsive to … |
View full post on asthma – Google News
|
Asthma specialist conducts session on latest clinical research
The News International Considering advances in asthma management, doctors and specialists must lay stress on the fact that patients can control their asthma, live an unrestricted life, and have normal activities. This was the key message communicated by Dr. Andrew Greening, … |
View full post on asthma – Google News
|
FDA Clears Palatin Technologies' IND Filing to Commence Clinical Studies for …
DigitalJournal.com (press release) "We are excited about the prospect of advancing PL-3994 into a Phase 2A human trial to treat asthma patients," stated Dr. Carl Spana, Palatin's Chief Executive Officer. "Existing therapies for acute exacerbations of asthma in patients unresponsive to … |
View full post on asthma – Google News
|
FDA Clears Palatin Technologies' IND Filing to Commence Clinical Studies for …
PR Newswire (press release) "We are excited about the prospect of advancing PL-3994 into a Phase 2A human trial to treat asthma patients," stated Dr. Carl Spana, Palatin's Chief Executive Officer. "Existing therapies for acute exacerbations of asthma in patients unresponsive to … |
View full post on asthma – Google News
 Washington University Record |
Combination therapy effective for asthma rescue
Clinical Advisor "Inhaled corticosteroids as rescue medication with albuterol might be an effective step-down strategy for children with well controlled mild asthma because it is more effective at reducing exacerbations than is use of rescue albuterol alone," Fernando … Children with mild asthma may benefit from intermittent treatment Inhaled Steroids to The Rescue |
View full post on asthma – Google News
 Consumer Affairs |
Asthma drug not safe for obstetric use
Clinical Advisor Terbutaline is currently approved to prevent and treat bronchospasm associated with asthma, bronchitis and emphysema, but has been used for obstetric purposes including preterm labor and treating uterine hyperstimulation in hospital settings. … FDA Issues Warning on Asthma Drug in Preterm Labor FDA Warns Against Certain Uses of Asthma Drug Terbutaline for Preterm Labor FDA Drug Safety Communication: New warnings against use of terbutaline to … |
View full post on asthma – Google News
|
Clinical Trials Update: Feb. 8, 2011
BusinessWeek Candidates must be aged 18 to 70 and diagnosed with asthma for at least two years. This study will evaluate a combination oral contraceptive. … |
View full post on asthma – Google News